Range
7.62 - 8.19
Vol / Avg.
41.4K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
191.7M
Payout Ratio
-
Open
7.82
P/E
-
EPS
-0.45
Shares
24M
Outstanding
24M
Total Float
12.2M
Sector: Health Care.Industry: Biotechnology
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-19
REV
Q2 2021Est.ActualSurprise
EPS-7.690
REV2.848M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

TScan Therapeutics Questions & Anwsers

Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by Cowen & Co. on August 13, 2021. The analyst firm set a price target for 0.00 expecting TCRX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $8 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

There are no upcoming dividends for TScan Therapeutics. The last dividend paid out to investors was $0.07 on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s $Q3 earnings are confirmed for after-market on $November 19, 2021.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.